News Focus
News Focus
Followers 0
Posts 89
Boards Moderated 0
Alias Born 06/23/2012

Re: errett post# 3760

Wednesday, 08/08/2012 1:29:45 PM

Wednesday, August 08, 2012 1:29:45 PM

Post# of 6072
I don't think anyone should look into the scheduled CC as positive or negative. All it says to me is that they want to discuss the FDA results whether it's approved or not. If it's approved, they talk about possible partnerships and/or the next steps. If it's not, they talk about Menadione and how there are still other products in the pipeline that could make TLON successful. The worst they could do is not say anything, so either way they will be prepared to make statements to the shareholders. After all, the CEO said he has the shareholders best interests in mind.

Where Real Traders Talk Markets

Join thousands of traders sharing insights, catalysts, and charts.

Join Today